Evernow grabs $28.5m Series A

Evernow, a telehealth company focused on treating women for perimenopause and menopause, has secured $28.5 million in Series A funding.

11 April 2022•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles